Longeveron Inc - ESG Rating & Company Profile powered by AI
This report of Longeveron Inc is assembled by All Street Sevva using advanced machine learning. Complete ESG analysis of Longeveron Inc can be reached by logging in. The webpage displays a free Sustainability report covering Longeveron Inc.
Longeveron Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.8; made up of an environmental score of 2.7, social score of 1.6 and governance score of 4.0.
2.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1353 | Vera Therapeutics Inc | 2.9 | Medium |
| 1353 | Veracyte Inc | 2.9 | Medium |
| 1393 | Longeveron Inc | 2.8 | Medium |
| 1393 | Bioventix PLC | 2.8 | Medium |
| 1393 | Bolt Biotherapeutics Inc | 2.8 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Longeveron Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Longeveron Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Longeveron Inc report the average age of the workforce?
Sign up for free to unlockDoes Longeveron Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Longeveron Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Longeveron Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Longeveron Inc offer flexible work?
Sign up for free to unlockDoes Longeveron Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Longeveron Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Longeveron Inc conduct supply chain audits?
Sign up for free to unlockDoes Longeveron Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Longeveron Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Longeveron Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Longeveron Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Longeveron Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Longeveron Inc disclose water use targets?
Sign up for free to unlockDoes Longeveron Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Longeveron Inc have a product recall in the last two years?
Sign up for free to unlockDoes Longeveron Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Longeveron Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Longeveron Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Longeveron Inc disclose parental leave metrics?
Sign up for free to unlockDoes Longeveron Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Longeveron Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Longeveron Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Longeveron Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Longeveron Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Longeveron Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Longeveron Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Longeveron Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Longeveron Inc disclose its waste policy?
Sign up for free to unlockDoes Longeveron Inc report according to TCFD requirements?
Sign up for free to unlockDoes Longeveron Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Longeveron Inc disclose energy use targets?
Sign up for free to unlockDoes Longeveron Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Longeveron Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Longeveron Inc
These potential risks are based on the size, segment and geographies of the company.
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.